CRISPR-Based Diagnostics and Antibody Therapies for COVID-19

The rapid evolution of viral pathogens requires cutting-edge biotechnological solutions for rapid detection and effective treatment. Understanding how genetic tools and immunology converge is key to grasping modern medical science.\n\nIn this text-based course, you will explore the science behind CRISPR-Cas diagnostics and antibody-based therapies. You will gain a solid foundation in molecular biology techniques, learning how researchers program genetic scissors to detect viral RNA and design targeted proteins to neutralize infections.\n\nWhat you will learn:\n- Understand the fundamental biology of viral infections, focusing on the mechanism of COVID-19.\n- Explore how CRISPR-Cas systems (including Cas12 and Cas13) are repurposed for rapid, high-precision diagnostic testing.\n- Analyze the development and therapeutic mechanisms of monoclonal antibodies in neutralizing viral targets.\n- Compare traditional diagnostic methods with modern, paper-based gene-detection technologies.\n- Examine how biotechnology adapts to emerging viral variants and mutations.\n\nThe course begins with essential concepts in molecular genetics and immunology before guiding you through the mechanisms of gene-editing diagnostics and therapeutic antibody design. You will read detailed case studies and engage with conceptual exercises designed to solidify your understanding of modern biotechnology.\n\nThis course is designed for curious beginners, students, and aspiring science professionals who want to understand modern biotech without needing a prior degree in biochemistry.\n\nStart reading today to demystify the genetic technologies shaping the future of global healthcare.